Pregnancy, Ovarian Clinical Trial
Official title:
Long Antagonist Protocol for IVF: a Proof of Concept for a Single Luteal GnRH- Antagonist Protocol
A prospective study of three different doses of Degarelix in late luteal phase of women undergoing ovarian stimulation for IVF
A prospective study of three different doses of Degarelix in late luteal phase of women
undergoing ovarian stimulation for IVF:Single dose of Degarelix 24mg, 16mg and 12 mg, on day
24th of previous luteal face cycle. On day 2 of the cycle: will be measured: LH levels,
estradiol levels, and FSH levels.
ON day 1 of the stimulation (depending day of the cycle): will be measured: LH levels,
estradiol levels, and FSH levels.
On day 6 of the stimulation( depending day of the cycle):will be measured: LH levels,
estradiol levels, and FSH levels.
On day 8 of the stimulation( depending day of the cycle):will be measured: LH levels,
estradiol levels, and FSH levels.
On day 10 of the stimulation( depending day of the cycle):will be measured: LH levels,
estradiol levels, and FSH levels.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03463278 -
The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate
|
||
| Completed |
NCT02442895 -
Biomarkers of Ovarian Reserve and Correlation With IVF Treatments
|
N/A | |
| Completed |
NCT00773825 -
Genomic Imprinting and Assisted Reproductive Technologies
|
N/A | |
| Recruiting |
NCT03684421 -
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol
|
||
| Recruiting |
NCT03693534 -
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol
|